NLRP3 and type 2 diabetes mellitus: The chronic inflammation of the patients contributes to the persistent activation of the NLRP3 inflammasome in SARS-CoV-2 infection, which may explain the relatively higher disease severity rate in patients with metabolic diseases such as type 2 diabetes [17,18], chronic liver disease [19], and acute myocardial infarction [20].